Omega Therapeutics Alpha and Beta Analysis
| OMGADelisted Stock | USD 0.05 0.01 21.25% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Omega Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Omega Therapeutics over a specified time horizon. Remember, high Omega Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Omega Therapeutics' market risk premium analysis include:
Beta 10.86 | Alpha 1.18 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Omega |
Omega Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Omega Therapeutics market risk premium is the additional return an investor will receive from holding Omega Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Omega Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Omega Therapeutics' performance over market.| α | 1.18 | β | 10.86 |
Omega Therapeutics Fundamentals Vs Peers
Comparing Omega Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Omega Therapeutics' direct or indirect competition across all of the common fundamentals between Omega Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Omega Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Omega Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Omega Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Omega Therapeutics to competition |
| Fundamentals | Omega Therapeutics | Peer Average |
| Return On Equity | -1.67 | -0.31 |
| Return On Asset | -0.25 | -0.14 |
| Operating Margin | (6.29) % | (5.51) % |
| Current Valuation | 100.44 M | 16.62 B |
| Shares Outstanding | 55.37 M | 571.82 M |
| Shares Owned By Insiders | 1.60 % | 10.09 % |
| Shares Owned By Institutions | 87.75 % | 39.21 % |
Omega Therapeutics Opportunities
Omega Therapeutics Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets - Marketscreener.com | 02/03/2025 |
2 | Omega Therapeutics Hits Chapter 11 - USA Herald | 02/10/2025 |
3 | OMEGA THERAPEUTICS INC Revenue Breakdown OTCOMGAQ - TradingView | 02/26/2025 |
About Omega Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Omega or other delisted stocks. Alpha measures the amount that position in Omega Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Omega Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Omega Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Omega Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Omega Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Omega Therapeutics. Please utilize our Beneish M Score to check the likelihood of Omega Therapeutics' management manipulating its earnings.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Omega Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Omega Stock
If you are still planning to invest in Omega Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Omega Therapeutics' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |